V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004205 | 10002658 | 1.67 | 79.5 | Unknown (U) | 2015-10-24 | 2015-10-25 | MaxiCHOP (Cycle 1) | 2 | N | 10512994 | CAPECITABINE + CISPLATIN |
| 10004206 | 10002659 | 1.72 | 81.4 | Adjuvant (A) | 2018-02-02 | 2018-02-02 | FEC + DOCETAXEL | N | N | 10512998 | FEC + DOCETAXEL |
| 10004207 | 10002660 | null | 75.9 | Curative (C) | 2014-09-23 | 2014-10-03 | EC | null | N | 10513057 | BORTEZOMIB |
| 10004208 | 10002661 | 1.69 | null | Adjuvant (A) | 2018-03-25 | 2018-03-26 | Fluorouracil + Folinic Acid Weekly | 2 | N | 10513178 | FLUOROURACIL |
| 10004209 | 10002662 | 1.6 | 87.6 | Curative (C) | 2017-07-22 | 2017-07-23 | Capecitabine + Cisplatin | 02 | N | 10513227 | CHOP |
| 10004210 | 10002663 | null | 77.2 | Palliative (P) | 2015-02-24 | 2015-03-16 | CISPLATIN + ETOPOSIDE | N | N | 10513232 | ABVD |
| 10004211 | 10002664 | 1.6 | 51.4 | Curative (C) | 2015-09-16 | 2015-10-06 | Cisplatin 100 + RT(H&N) 1 day | 2 | Y | 10513330 | CISPLATIN + RT |
| 10004212 | 10002665 | 1.5 | 62.9 | Curative (C) | 2018-05-28 | 2018-06-03 | CISPLATIN + RT | 02 | null | 10513378 | CISPLATIN + RT |
| 10004213 | 10002666 | 1.74 | 82.8 | Adjuvant (A) | 2017-02-23 | 2017-02-23 | FLUOROURACIL | N | N | 10513452 | FLUOROURACIL |
| 10004214 | 10002666 | 1.79 | 86 | Palliative (P) | 2016-07-04 | 2016-07-16 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10513452 | CTD |
| 10004215 | 10002667 | 1.6 | null | Palliative (P) | 2015-03-14 | 2015-04-08 | FLUOROURACIL + IRINOTECAN | N | N | 10513618 | IRINOTECAN + MDG |
| 10004216 | 10006599 | 1.81 | 132 | Palliative (P) | 2016-08-17 | 2016-08-18 | Cisplatin 7 day | 02 | N | 10513668 | EC |
| 10004217 | 10002668 | 1.56 | null | Adjuvant (A) | 2018-04-20 | 2018-05-13 | Fluorouricil + Folonic Acid (MdG) | N | N | 10513688 | FLUOROURACIL |
| 10004218 | 10006600 | 1.75 | 75 | Palliative (P) | 2016-04-15 | 2016-04-18 | BCG Intravesical | N | N | 10513745 | EC |
| 10004219 | 10006600 | null | 85.7 | Curative (C) | 2016-10-04 | 2016-10-13 | CYCLOPHOSPHAMIDE + THALIDOMIDE | null | N | 10513745 | CTD |
| 10004220 | 10006600 | null | 49.3 | Adjuvant (A) | 2017-08-21 | 2017-09-02 | CISPLATIN + ETOPOSIDE | 2 | N | 10513745 | BCG |
| 10004221 | 10002669 | 1.66 | 71 | Palliative (P) | 2016-01-10 | 2016-01-24 | Bortezomib (weekly) | N | Y | 10513915 | FLUOROURACIL + MITOMYCIN + RT |
| 10004222 | 10002670 | 1.75 | 82.4 | Palliative (P) | 2015-11-08 | 2015-11-28 | Fluorouracil + Folinic Acid Weekly | N | N | 10513918 | FLUOROURACIL |
| 10004223 | 10002671 | 1.7 | null | Palliative (P) | 2016-02-03 | 2016-02-09 | Irinotecan + Modified De Gramont | N | N | 10514057 | IRINOTECAN + MDG |
| 10004224 | 10002671 | 1.82 | 74 | Adjuvant (A) | 2016-05-24 | 2016-05-27 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 10514057 | FLUOROURACIL |
| 10004225 | 10002672 | 1.51 | 52 | Neo-adjuvant (N) | 2015-12-30 | 2016-01-01 | CHOP - 21 days | N | N | 10514080 | CISPLATIN + ETOPOSIDE |
| 10004226 | 10002673 | 1.88 | 96.2 | Not known (9) | 2018-05-08 | 2018-05-08 | Fluorouricil + Folonic Acid (MdG) | N | N | 10514123 | FLUOROURACIL |
| 10004227 | 10002674 | 1.77 | 70.4 | Neo-adjuvant (N) | 2016-01-19 | 2016-01-25 | FEC 100 + DOCETAXEL | N | N | 10514150 | FEC + DOCETAXEL |
| 10004228 | 10002675 | 1.58 | 70.4 | Palliative (P) | 2017-08-25 | 2017-09-07 | CTD Attenuated (Thalidomide 50mg) | N | N | 10514212 | CAPECITABINE + CISPLATIN |
| 10004229 | 10002676 | 1.75 | 111 | Adjuvant (A) | 2018-10-05 | 2018-10-06 | Temozolomide + RT | 02 | N | 10514233 | CHLORAMBUCIL |
| 10004230 | 10002677 | 1.52 | 66.2 | Disease modification (D) | null | 2015-02-12 | Bortezomib + Cyclophos + Dex | 2 | null | 10514292 | CAPECITABINE + GEMCITABINE |
| 10004231 | 10002678 | 1.6 | 69 | Curative (C) | 2019-06-12 | 2019-06-19 | CISPLATIN + ETOPOSIDE | 02 | N | 10514297 | CHLORAMBUCIL |
| 10004232 | 10002678 | 1.55 | 101 | Adjuvant (A) | 2015-01-13 | 2015-01-13 | FLUOROURACIL | 02 | N | 10514297 | FLUOROURACIL |
| 10004233 | 10002679 | 1.61 | 72.9 | Curative (C) | 2017-01-09 | 2017-01-17 | Capecitabine 35days + RT | 02 | N | 10514415 | CAPECITABINE + RT |
| 10004234 | 10002680 | 1.6 | 79 | Palliative (P) | 2018-06-15 | 2018-06-21 | Irinotecan + Modified De Gramont | 02 | N | 10514463 | IRINOTECAN + MDG |
| 10004235 | 10002680 | 1.7 | 75 | Neo-adjuvant (N) | null | 2016-08-23 | Cisplatin | N | N | 10514463 | CAPECITABINE + GEMCITABINE |
| 10004236 | 10002681 | 1.58 | 49.9 | Neo-adjuvant (N) | 2018-01-09 | 2018-02-20 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10514592 | AZACITIDINE |
| 10004237 | 10002682 | 1.8 | 65 | Curative (C) | 2017-04-30 | 2017-05-01 | Bortezomib +/- Dexamethasone | 02 | N | 10514627 | CHOP |
| 10004238 | 10002683 | 1.8 | 94.2 | Curative (C) | 2016-04-10 | 2016-05-01 | Abiraterone | 02 | N | 10514673 | PACLITAXEL |
| 10004239 | 10002683 | 1.65 | 84 | Curative (C) | 2018-05-02 | 2018-05-02 | BCG Intravesical | 02 | N | 10514673 | CAPECITABINE + GEMCITABINE |
| 10004240 | 10002684 | 1.79 | 0 | Disease modification (D) | 2016-02-13 | 2016-03-14 | CAPECITABINE + GEMCITABINE | null | null | 10514834 | CHLORAMBUCIL |
| 10004241 | 10002685 | null | null | Curative (C) | 2018-03-07 | 2018-03-08 | CHOP - 21 days | N | N | 10514841 | PACLITAXEL |
| 10004242 | 10002686 | 1.6 | 70.4 | Adjuvant (A) | 2015-01-12 | 2015-01-19 | Cisplatin + Etoposide (3 day) | 2 | N | 10514873 | ABVD |
| 10004243 | 10006605 | 1.65 | 75 | Neo-adjuvant (N) | 2018-05-20 | 2018-06-07 | CTD Attenuated (Thalidomide 50mg) | 02 | Y | 10514905 | CHLORAMBUCIL |
| 10004244 | 10002687 | 1.59 | 63.8 | Not known (9) | 2015-06-15 | 2015-06-25 | CHOP - 21 days | N | N | 10515072 | CAPECITABINE + GEMCITABINE |
| 10004245 | 10002688 | 1.71 | 78 | Curative (C) | 2016-08-06 | 2016-08-08 | FEC + DOCETAXEL | 2 | N | 10515073 | FEC + DOCETAXEL |
| 10004246 | 10002688 | null | null | null | 2016-10-09 | 2016-10-09 | EC | N | null | 10515073 | EC |
| 10004247 | 10002689 | 1.63 | 113 | Adjuvant (A) | 2017-01-30 | 2017-01-31 | Cisplatin 7 day | 02 | N | 10515238 | AZACITIDINE |
| 10004248 | 10002689 | 1.56 | 82 | Adjuvant (A) | 2017-06-03 | 2017-06-18 | FEC 100 + DOCETAXEL | N | N | 10515238 | FEC + DOCETAXEL |
| 10004249 | 10002690 | 1.59 | null | Curative (C) | 2014-06-15 | 2014-07-01 | Cisplatin | 02 | Y | 10515296 | TEMOZOLOMIDE + RT |
| 10004250 | 10006608 | 1.73 | 61.8 | null | 2018-08-07 | 2018-08-07 | CAPECITABINE + RT | 02 | Y | 10515301 | CAPECITABINE + RT |
| 10004251 | 10002691 | 1.83 | null | Neo-adjuvant (N) | null | 2016-06-09 | Azacitidine | null | N | 10515334 | AZACITIDINE |
| 10004252 | 10002691 | 1.7 | 89.6 | Neo-adjuvant (N) | 2017-11-01 | 2017-11-01 | Abiraterone | 02 | N | 10515334 | CVD |
| 10004253 | 10002692 | 0 | 73.8 | Palliative (P) | 2015-04-26 | 2015-04-27 | Bortezomib +/- Dexamethasone | Y | N | 10515420 | AZACITIDINE |
| 10004254 | 10002693 | 1.7 | 48 | Adjuvant (A) | 2018-07-02 | 2018-07-22 | ABVD | N | N | 10515485 | ABIRATERONE |